Journal of Biological Chemistry
Volume 277, Issue 6, 8 February 2002, Pages 4088-4097
Journal home page for Journal of Biological Chemistry

GENES: STRUCTURE AND REGULATION
Effects of B-Myb on Gene Transcription: PHOSPHORYLATION-DEPENDENT ACTIVITY AND ACETYLATION BY p300*

https://doi.org/10.1074/jbc.M105112200Get rights and content
Under a Creative Commons license
open access

The transcription factor B-Myb is a cell-cycle regulated phosphoprotein involved in cell cycle progression through the transcriptional regulation of many genes. In this study, we show that the promoter of the fibroblast growth factor-4(FGF-4) gene is strongly activated by B-Myb in HeLa cells and it can serve as a novel diagnostic tool for assessing B-Myb activity. Specifically, B-Myb deletion mutants were examined and domains of B-Myb required for activation of the FGF-4promoter were identified. Using phosphorylation-deficient mutant forms of B-Myb, we also show that phosphorylation is essential for B-Myb activity. Moreover, a mutant form of B-Myb, which lacks all identified phosphorylation sites and which has little activity, can function as a dominant-negative and suppress wild-type B-Myb activity. Acetylation is another post-translational modification known to affect the activity of other Myb family members. We show that B-Myb is acetylated by the co-activator p300. We also show that the bromo and histone acetyltransferase domains of p300 are sufficient to interact with and acetylate B-Myb. These data indicate that phosphorylation of B-Myb is an essential modification for activity and that acetylation of B-Myb may play a role in B-Myb activity.

Cited by (0)

Published, JBC Papers in Press, December 3, 2001, DOI 10.1074/jbc.M105112200

*

This work was supported in part by National Institutes of Health NCI Grants CA74771 (to A. R.) and CA79491 (to A. R.), American Cancer Society Grant BE-260 (to R. L.), and core facilities of the University of Nebraska Medical Center Eppley Cancer Center used in the course of this work were supported in part by National Institutes of Health NCI Laboratory Cancer Research Support Grant CA36727.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Supported in part by National Institutes of Health NCI Training Grant CA09476.